- Home
- ATRC vs EVT Comparison
ATRC vs EVT Comparison
Compare ATRC & EVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRC
- EVT
- Stock Information
- Founded
- ATRC 2000
- EVT 2003
- Country
- ATRC United States
- EVT United States
- Employees
- ATRC N/A
- EVT N/A
- Industry
- ATRC Medical/Dental Instruments
- EVT Finance Companies
- Sector
- ATRC Health Care
- EVT Finance
- Exchange
- ATRC Nasdaq
- EVT Nasdaq
- Market Cap
- ATRC 1.5B
- EVT 1.7B
- IPO Year
- ATRC 2005
- EVT N/A
- Fundamental
- Price
- ATRC $34.57
- EVT $23.21
- Analyst Decision
- ATRC Strong Buy
- EVT
- Analyst Count
- ATRC 10
- EVT 0
- Target Price
- ATRC $49.60
- EVT N/A
- AVG Volume (30 Days)
- ATRC 581.4K
- EVT 140.9K
- Earning Date
- ATRC 04-29-2025
- EVT 01-01-0001
- Dividend Yield
- ATRC N/A
- EVT 8.50%
- EPS Growth
- ATRC N/A
- EVT N/A
- EPS
- ATRC N/A
- EVT 6.63
- Revenue
- ATRC $480,076,000.00
- EVT $69,404,302.00
- Revenue This Year
- ATRC $14.63
- EVT N/A
- Revenue Next Year
- ATRC $12.62
- EVT N/A
- P/E Ratio
- ATRC N/A
- EVT $3.51
- Revenue Growth
- ATRC 15.79
- EVT N/A
- 52 Week Low
- ATRC $18.94
- EVT $19.20
- 52 Week High
- ATRC $43.11
- EVT $25.83
- Technical
- Relative Strength Index (RSI)
- ATRC 60.03
- EVT 55.70
- Support Level
- ATRC $31.95
- EVT $22.89
- Resistance Level
- ATRC $34.08
- EVT $23.29
- Average True Range (ATR)
- ATRC 1.14
- EVT 0.35
- MACD
- ATRC 0.31
- EVT -0.03
- Stochastic Oscillator
- ATRC 94.66
- EVT 54.12
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
About EVT Eaton Vance Tax Advantaged Dividend Income Fund of Beneficial Interest
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND is a diversified, closed-end management investment company. Its objective is to provide a high level of after-tax total return consisting mainly of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of electric utilities, energy equipment and services, food products, health care providers and services, internet software and services, and other areas.